Login
Toggle navigation
Videos
Categories
Trending
4D Pharma raises $40 million - Duncan Peyton, CEO, 4D Pharma
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
4D Pharma raises $40 million in a Nasdaq listing
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Revolutionizing Copper Mining: Excelsior Mining's Innovative Approach to Sustainable Production
00:10:00
SuperReturn International hosts Steve Klinsky from New Mountain Capital and Jake Elmhirst from UBS for discussions on investment strategies and market trends.
00:10:00
Electric utility in the Cayman Islands outlines growth trajectory and renewable energy initiatives, underscoring stability and attractive investor returns | Richard Hew, CEO,Caribbean Utilities Company Ltd.
00:10:00
Karla Briones Discusses the Immigrants Developing Entrepreneurs Academy (IDEA) and Its Benefits
00:10:00
Valera Rocks Prepares for ASX IPO with Advanced Exploration Projects in NSW and WA
00:10:00
Gold Mining Operations and Market Dynamics
00:10:00
Battery Minerals: Near-Term Graphite Production in Mozambique Set to Boost Shareholder Value
00:10:00
What got funded and who are the winners/losers|Wilson Kyi, partenr,Basis Set Ventures
00:10:00
Pexa's Path to Growth: CEO Glenn King Discusses Expansion, Performance, and Outlook in Stock Network Interview.
00:10:00
Welcome to Pope Financial Planning: A Message from the Founder | Apryl M. Pope - Owner & Founder of Pope Financial Planning
00:10:00
coming from being a woman in venture capital who adapted to this new career path|Amy Saper,Partner,Accel
00:10:00
Replay: Gibson Dunn Webinar | The Lawyer Portal | Barbara L. Becker - Chair & Managing Partner of gibson dunn